Safety and pharmacokinetic profile of rufinamide in pediatric patients aged less than 4 years with Lennox-Gastaut syndrome: An interim analysis from a multicenter, randomized, active-controlled, open-label study - Arzimanoglou, A; Ferreira, J A; Satlin, A (Eur J Paediatr Neurol, 2016)
, et al.